The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
Modlin I, Kidd M, Bodei L, Drozdov I, Aslanian H. The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract. The American Journal Of Gastroenterology 2015, 110: 1223. PMID: 26032155, DOI: 10.1038/ajg.2015.160.Peer-Reviewed Original ResearchConceptsPancreatic neuroendocrine tumorsNeuroendocrine tumorsCgA measurementMalignant gastrointestinal diseasesBlood-based biomarkersNeuroendocrine tumor diseaseExtensive diseaseIntestinal carcinoidsColorectal cancerGastrointestinal diseasesCgA levelsPancreatic diseaseClinical utilityGastrointestinal tractDiagnostic strategiesNETestDiseaseTumorsNETest scoreTumor diseaseNovel bloodNational InstituteDiagnosisBiomarkersCgA
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply